Text Size
30 studies found for:    " October 02, 2012":" November 01, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df
2 Recruiting Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df;   Drug: ritonavir + atazanavir + emtricitabine/tenofovir df
3 Recruiting A Prospective, Observational Study to Examine the Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'
Conditions: HIV Positive;   Ageing
Intervention:
4 Not yet recruiting Comparison of 2 IUDnCT Devices
Condition: Comparing Safety With Regard to HIV Disease Progression and Acceptability of Levonorgestrel IUD to the Copper IUD Among HIV-infected ART-naïve Women.
Intervention: Device: Mirena levonorgestrel IUD and copper T-380a IUD
5 Not yet recruiting A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
Condition: HCV and HIV Seropositive Coinfection
Interventions: Drug: boceprevir;   Drug: Ribavirin;   Drug: Peginterferon alfa-2a;   Drug: Peginterferon alfa-2b
6 Recruiting Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
7 Recruiting Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
Condition: HIV-1 Infection
Intervention:
8 Recruiting First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition: HIV
Interventions: Drug: Maraviroc;   Drug: TVD 300/200 QD
9 Active, not recruiting Comparison of HIV Testing Algorithms
Condition: HIV Infection
Intervention: Other: application of a confirmation test
10 Active, not recruiting Re-boosting of HIV-1 Infected Subjects With Vacc-4x
Condition: HIV-1 Infection
Intervention: Biological: Vacc-4x
11 Not yet recruiting CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
Condition: Human Immunodeficiency Virus
Interventions: Device: Intervention Arm (computer-based CARE+ Corrections tool);   Other: Educational video on opiate overdose prevention
12 Not yet recruiting A Study to Compare Efficacy in Terms of Plasma Human Immunodeficiency Virus-Type 1 (HIV-1) Ribonucleic Acid (RNA) Between 2 Fixed Dose Combinations After a Switch in Fully Suppressed Patients
Condition: Human Immunodeficiency Virus-type 1 Infection
Interventions: Drug: Rilpivirine;   Drug: Efavirenz;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine
13 Recruiting A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen
Condition: HIV-1 Infection
Interventions: Drug: FZD;   Drug: 3TC;   Drug: EFV;   Drug: AZT
14 Recruiting A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With HIV-1
Condition: HIV Infection
Interventions: Drug: Raltegravir Film-coated Tablet;   Drug: Raltegravir Chewable Tablet
15 Not yet recruiting Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin
Conditions: AIDS;   Tuberculosis
Intervention: Drug: Lopinavir/ritonavir and ritonavir
16 Recruiting Online Social Networks for HIV Prevention Among African American and Latino MSM
Condition: HIV
Intervention: Behavioral: HIV knowledge Intervention
17 Recruiting Network Supported Engagement In HIV Care
Conditions: HIV;   Patient Acceptance of Health Care
Intervention: Other: Supportive Care
18 Recruiting Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
Conditions: HIV;   Hypercholesterolemia;   Dyslipidemia
Intervention:
19 Recruiting Antimalarial Pharmacology in Children and Pregnant Women in Uganda
Conditions: Malaria;   HIV
Intervention:
20 Recruiting SANKOFA Pediatric HIV Disclosure Intervention
Condition: HIV
Interventions: Behavioral: Disclosure intervention;   Behavioral: Enhanced usual care
To Top

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
† Indicates status has not been verified in more than two years